The M5 chip's 3-nanometer breakthrough is pushing the entire industry forward, creating massive demand for the specialised equipment and services these companies provide.
With major improvements in AI processing power, these semiconductor suppliers are at the heart of the artificial intelligence boom that's reshaping consumer electronics.
Whilst everyone focuses on the end product, smart investors are looking upstream to the essential companies that make cutting-edge chips possible in the first place.
Summarised interpretation of market capitalisation for the provided semiconductor supply chain basket, including investor-focused key takeaways.
AAPL: $3.70T
TSM: $1.24T
ASML: $393.24B
Apple's M5 chip launch represents a major leap in 3-nanometer technology, creating a ripple effect throughout the semiconductor industry. This advancement drives demand for sophisticated manufacturing processes and specialised equipment, benefiting the entire supply chain that makes such cutting-edge processors possible.
This group focuses on the foundational companies behind next-generation chip production - from foundry services and manufacturing equipment to electronic design automation. These businesses are positioned to benefit from the escalating demand for advanced semiconductors across AI and consumer electronics applications.
Each company was handpicked by professional analysts for their essential role in the semiconductor ecosystem. They represent global leaders in foundry services, specialised equipment manufacturers, and firms involved in electronic design - all critical players enabling the next generation of computing technology.
Apple's launch of the M5 chip highlights a significant leap in 3-nanometer technology, creating investment opportunities beyond Apple itself. This theme focuses on the key semiconductor companies that supply the advanced technology and equipment essential for producing such next-generation chips.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Published on October 16
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
+5
Here are a few of the assets in this group. Create an account to unlock the full list.
Join Nemo FREE today and unlock every stock
It only takes 60 seconds.
11 of 14 assets in this group are rated Buy by professional analysts.
